Targeting Gene Therapy for Prostate Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
531-555
Author(s):
N. J. Maitland, L. J. Stanbridge and V. Dussupt
Angiogenesis Inhibitors: Current & Future Directions
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1-9
Author(s):
Shaker A. Mousa and Ahmed S. Mousa
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Resistance to Anti-VEGF Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
51-64
Author(s):
Ton N. C. and Jayson G. C.
Designing of Novel Carbonic Anhydrase Inhibitors and Activators
Journal:
Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume:
2
Page:
49-68
Author(s):
Claudiu T. Supuran, Daniela Vullo, Gheorghe Manole, Angela Casini and Andrea Scozzafava
Histone Deacetylase Inhibitors: From Chromatin Remodeling to Experimental Cancer Therapeutics
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
2343-2350
Author(s):
Janine Arts, Stefanie de Schepper and Kristof Van Emelen
The Quest for a Tumor Suppressor Gene Phenotype
Journal:
Current Molecular Medicine
Volume:
3
Page:
605-629
Author(s):
Nadege Presneau, Emily N. Manderson and Patricia N. Tonin
Molecular Mechanisms of Tumor Invasion and Metastasis: An Integrated View
Journal:
Current Molecular Medicine
Volume:
3
Page:
659-671
Author(s):
R. A. Cairns, R. Khokha and R. P. Hill
Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2009-2023
Author(s):
Elke S. Bergmann-Leitner, Elizabeth H. Duncan and Wolfgang W. Leitner
Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2067-2077
Author(s):
J. Brtko and J. Thalhamer